Pharmaceutical & life sciences
GDP-validated storage, vaccine cold chain & biotech
Validated +2/+8 °C and −20 °C facilities for distributors, manufacturers and hospital networks. Built for 21 CFR Part 11 and WHO GDP audits.
Key challenges
- Zero-deviation temperature performance
- Validation, mapping and qualification timelines
- Redundancy in high-ambient regions
ColdMatch solutions
- N+1 redundant chillers with backup generation
- Validated mapping, alarms and 24/7 monitoring
- Cleanroom-compatible MEP coordination
Typical projects & capex
| Project type | Capex range |
|---|---|
| Pharmacy chamber | $50K – $250K |
| Vaccine distribution hub | $2M – $12M |
| Biotech storage + −80 °C | $1M – $8M |
Frequently asked questions — Pharmaceutical & life sciences
Can a pharma brief require GDP-documented suppliers?+
Yes. The brief can require documented GDP, GMP, ISO 9001 and, where relevant, FDA project history, and suppliers are asked to provide that evidence. For projects of USD 250,000 or more, the ColdMatch team reviews the brief, contacts suitable suppliers on your behalf and presents their responses in an organized format; ColdMatch does not certify suppliers.
Can we get redundant cooling for vaccine and biologics storage?+
Yes — the brief can specify N+1 redundancy, backup generation and validated 21 CFR Part 11 monitoring, and suppliers are asked to quote against those requirements so responses can be compared on the same scope.
How long does validation and licensing typically take?+
Mapping, qualification and ministry licensing usually run 4–8 months in parallel with construction. Plan validation scope in the brief so suppliers price it on the same basis.
Can ColdMatch help finance a pharma cold-storage build?+
ColdMatch does not lend or give financial advice. Qualified projects may be introduced to independent financing partners, who make their own decisions. See the financing page.